MAIA Biotechnology, Inc. (MAIA)
1.15
+0.02
(+1.77%)
USD |
NYAM |
Oct 23, 16:00
1.145
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology EPS Diluted (Quarterly) : -0.1307 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1307 |
| March 31, 2026 | -0.1409 |
| December 31, 2025 | -0.094 |
| September 30, 2025 | -0.2682 |
| June 30, 2025 | -0.1765 |
| March 31, 2025 | -0.1631 |
| December 31, 2024 | -0.1366 |
| September 30, 2024 | -0.1145 |
| June 30, 2024 | -0.3999 |
| March 31, 2024 | -0.4583 |
| December 31, 2023 | -0.3683 |
| September 30, 2023 | -0.3565 |
| Date | Value |
|---|---|
| June 30, 2023 | -0.3511 |
| March 31, 2023 | -0.375 |
| December 31, 2022 | -0.3784 |
| September 30, 2022 | -0.4824 |
| June 30, 2022 | -0.4033 |
| March 31, 2022 | -0.3633 |
| December 31, 2021 | -0.272 |
| September 30, 2021 | -0.4886 |
| June 30, 2021 | -0.3137 |
| March 31, 2021 | -0.0925 |
| September 30, 2020 | -0.0689 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.944M |
| Total Expenses (Quarterly) | 7.944M |
| Enterprise Value | 42.34M |
| Earnings Yield | -55.11% |
| Normalized Earnings Yield | -56.47 |